Skip to content
Research Article Open access CC BY 4.0

Examining the Impact of Patient-Reported Hope for Improvement and Patient Satisfaction with Clinician/Treatment on the Outcome of Major Depressive Disorder Treatment

Waguih William IsHak, Jennice Vilhauer, Richard Kwock, Fan Wu, Sherif Gohar, Katherine Collison, Shannon Nicole Thomas, Lancer Naghdechi, David Elashoff

International Neuropsychiatric Disease Journal · pp. 1–10 · Published 9 May 2016

10.9734/INDJ/2016/26203

Abstract

Aims: This analysis aims at examining if patient-reported variables such as hope for improvement and patient satisfaction with clinician/treatment could influence the outcome major depressive disorder (MDD) treatment, namely depression remission, in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) trial. Study Design: Retrospective cohort study. Place and Duration of Study: The STAR*D study was conducted at 18 primary care and 23 psychiatric care settings in the United States from 2001-2007 and was funded by the National Institute of Mental health (NIMH). The analysis contained in this manuscript was conceptualized at the Cedars-Sinai Department of Psychiatry and Behavioral Neurosciences and performed at the UCLA School of Public Health. Methodology: Using data from STAR*D, the current study used logistic regression and survival analyses to examine the relationship between depressive symptoms remission and two sets of self-reported factors: Hope for improvement and, Patient satisfaction with treatment/clinician. Results: First, more than 90% of STAR*D patients reported having high hope for improvement (agree or strongly agree) and more than 66% endorsed high satisfaction with clinicians and more than 50% expressed high satisfaction with treatments (very or mostly satisfied). Second, hope for improvement was predictive of depression remission (p<0.05). Third, satisfaction with clinician/treatment, did not predict remission. Conclusion: This study shows the impact that patients’ subjective hope for improvement can have on predicting depression remission in contrast to satisfaction with clinician/treatment. Future studies should prospectively incorporate patients’ subjective attitudes regarding hope for improvement and satisfaction with clinicians and treatments as mediators and moderators of MDD treatment success.

Major depressive disorder hope patient satisfaction remission

References (27)

  1. 1 Projections of Global Mortality and Burden of Disease from 2002 to 2030 [DOI]
  2. 2 Aspirin plus Clopidogrel as Secondary Prevention after Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis [DOI]
  3. 3 Relation of the therapeutic alliance with outcome and other variables: A meta-analytic review. [DOI]
  4. 4 Initial Severity and Antidepressant Benefits: A Meta-Analysis of Data Submitted to the Food and Drug Administration [DOI]
  5. 5 Research summary on the therapeutic relationship and psychotherapy outcome. [DOI]
  6. 6 Placebo Response in Studies of Major Depression [DOI]
  7. 7 Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design [DOI]
  8. 8 The Acceptability of Treatment for Depression Among African-American, Hispanic, and White Primary Care Patients [DOI]
  9. 9 Patient predictors of response to psychotherapy and pharmacotherapy: findings in the NIMH Treatment of Depression Collaborative Research Program [DOI]
  10. 10 Background and rationale for the Sequenced Treatment Alternatives to Relieve Depression (STAR∗D) study [DOI]
  11. 11 Patients' preferences in the treatment of depressive disorder in primary care [DOI]
  12. 12 The Relationship of Patient Satisfaction with Care and Clinical Outcomes [DOI]
  13. 13 Expectations [DOI]
  14. 14 Quality of Life: The Ultimate Outcome Measure of Interventions in Major Depressive Disorder [DOI]
  15. 15 A Systematic Review of Comparative Efficacy of Treatments and Controls for Depression [DOI]
  16. 16 Quality of life in major depressive disorder before/after multiple steps of treatment and one‐year follow‐up [DOI]
  17. 17 Treating Major Depression by Creating Positive Expectations for the Future: A Pilot Study for the Effectiveness of Future‐Directed Therapy (FDT) on Symptom Severity and Quality of Life [DOI]
  18. 18 Conditioning, Expectancy, and the Placebo Effect: Comment on Stewart-Williams and Podd (2004). [DOI]
  19. 19 Role of pill-taking, expectation and therapeutic alliance in the placebo response in clinical trials for major depression [DOI]
  20. 20 Patients’ outcome expectancies and their impression of suitability as predictors of treatment outcome [DOI]
  21. 21 Medication beliefs and adherence to antidepressants in primary care [DOI]
  22. 22 Treatment attitudes and adherence of psychiatric patients with major depressive disorder: A five-year prospective study [DOI]
  23. 23 Relationship Between Satisfaction, Patient-Centered Care, Adherence and Outcomes Among Patients in A Collaborative Care Trial for Depression [DOI]
  24. 24 Improving Quality of Life for Patients with Major Depressive Disorder by Increasing Hope and Positive Expectations with Future Directed Therapy (FDT).
  25. 25 Satisfaction With Medication Is Correlated With Outcome but Not Persistence in Patients Treated With Placebo, Escitalopram, or Serotonin-Norepinephrine Reuptake Inhibitors [DOI]
  26. 26 Translational research in the decade of discovery [DOI]
  27. 27 The costs of treating depression.

Cited by 2

Article metrics

Real usage data collected on this platform.

25

Page views

0

PDF downloads

9

Outbound clicks

2

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.